• Gyre Therapeutics COO Ye Weiguo exercised stock options on June 4-5, acquiring 34,976 common shares at $0.75.
• He sold 34,976 common shares those same days at weighted-average prices of $6.13 and $6.4.
• His direct holdings were unchanged at 700,000 common shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gyre Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-024449), on June 08, 2026, and is solely responsible for the information contained therein.